INDEVR, INC.

Company Information

Company Name
INDEVR, INC.
Address
2100 Central Ave, Suite 106
BOULDER, CO, 80301-2887
Phone
n/a
URL
n/a
DUNS
132347787
Number of Employees
n/a
Woman Owned

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$2,394,672.00
4
SBIR Phase II
$8,245,276.00
3
STTR Phase I
$932,297.00
1
Chart code to be here

Award List

  1. Advanced Detection Technologies for Biochips

    Amount: $932,297.00

    DESCRIPTION (provided by applicant): The long-term objective of the proposed work is the development of innovative detection technologies for biochips (a.k.a. DNA microarrays). It is envisioned that ...

    STTR Phase I 2004 Department of Health and Human Services
  2. Monitoring System For Vector-Based Influenza Vaccine

    Amount: $597,544.00

    DESCRIPTION (provided by applicant): This Advanced Technology proposal is in response to NIAID's recently issued Notice of High-Priority Influenza Research Areas [NOT-AI-05-013]. In order to provide ...

    SBIR Phase I 2006 Department of Health and Human Services
  3. Monitoring System For Vector-Based Influenza Vaccine

    Amount: $2,401,162.00

    DESCRIPTION (provided by applicant): This Phase II Advanced Technology SBIR [PA-06-134] proposal is in response to NIAID's Notice of High-Priority Influenza Research Areas [NOT-AI-05-013]. In order to ...

    SBIR Phase II 2008 Department of Health and Human Services
  4. SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES

    Amount: $597,128.00

    DESCRIPTION (provided by applicant): Our objective is to develop a commercially viable influenza diagnostic for rapid and simultaneous screening of clinical samples for influenza A and B type and impo ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES

    Amount: $2,988,813.00

    DESCRIPTION (provided by applicant): The objective for this Phase II application is to develop a cartridge-based automated molecular diagnostic platform to rapidly and cost-effectively detect and iden ...

    SBIR Phase II 2011 Department of Health and Human Services
  6. TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): There is a tremendous need for new analytical methods to enhance vaccine research and development, ultimately allowing the production of safe and efficacious vacci ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. INNOVATIVE OPTICAL SYSTEM FOR HEMAGGLUTINATION ASSAYS

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): We propose to eliminate the time-consuming manual plate readout for hemagglutination assays by developing an innovative 96-well plate and associated optical reader ...

    SBIR Phase I 2014 Department of Health and Human Services
  8. TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION

    Amount: $2,855,301.00

    DESCRIPTION (provided by applicant): It is widely acknowledged that for split vaccines, potency determination is often a rate limiting step. The FDA approved gold standard potency assay for influenz ...

    SBIR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government